Wedbush Securities’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,400
| Closed | -$268K | – | 1281 |
|
|
2023
Q4 | $268K | Hold |
14,400
| – | – | 0.01% | 822 |
|
|
2023
Q3 | $159K | Hold |
14,400
| – | – | 0.01% | 953 |
|
|
2023
Q2 | $233K | Hold |
14,400
| – | – | 0.01% | 867 |
|
|
2023
Q1 | $240K | Sell |
14,400
-400
| -3% | -$6.67K | 0.01% | 847 |
|
|
2022
Q4 | $139K | Hold |
14,800
| – | – | 0.01% | 959 |
|
|
2022
Q3 | $40K | Hold |
14,800
| – | – | ﹤0.01% | 1015 |
|
|
2022
Q2 | $43K | Hold |
14,800
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q1 | $44K | Hold |
14,800
| – | – | ﹤0.01% | 1080 |
|
|
2021
Q4 | $68K | Sell |
14,800
-1,700
| -10% | -$7.81K | ﹤0.01% | 1147 |
|
|
2021
Q3 | $104K | Buy |
+16,500
| New | +$104K | ﹤0.01% | 1130 |
|
|
2021
Q2 | – | Sell |
-16,500
| Closed | -$104K | – | 1195 |
|
|
2021
Q1 | $104K | Sell |
16,500
-2,500
| -13% | -$15.8K | 0.01% | 1043 |
|
|
2020
Q4 | $107K | Sell |
19,000
-2,500
| -12% | -$14.1K | 0.01% | 828 |
|
|
2020
Q3 | $125K | Buy |
21,500
+2,500
| +13% | +$14.5K | 0.01% | 806 |
|
|
2020
Q2 | $137K | Hold |
19,000
| – | – | 0.01% | 832 |
|
|
2020
Q1 | $89K | Sell |
19,000
-207
| -1% | -$970 | 0.01% | 782 |
|
|
2019
Q4 | $154K | Hold |
19,207
| – | – | 0.01% | 897 |
|
|
2019
Q3 | $132K | Buy |
19,207
+7,500
| +64% | +$51.5K | 0.01% | 874 |
|
|
2019
Q2 | $97K | Buy |
+11,707
| New | +$97K | 0.01% | 906 |
|